Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 8.97% vs 13.29% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 26.33% vs 28.31% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 54.43% vs -5.14% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 29.87% vs 43.89% in Mar 2024
Compare Profit and Loss Results of Indrapr.Medical
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,356.00
1,060.00
296.00
27.92%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,356.00
1,060.00
296.00
27.92%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
27.00
17.00
10.00
58.82%
Employee Cost
277.00
161.00
116.00
72.05%
Operating Expenses
254.00
300.00
-46.00
-15.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
85.00
5.00
80.00
1,600.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
59.00
5.00
54.00
1,080.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,112.00
875.00
237.00
27.09%
Operating Profit (PBDIT) excl Other Income
244.00
185.00
59.00
31.89%
Other Income
22.00
29.00
-7.00
-24.14%
Operating Profit (PBDIT)
266.00
215.00
51.00
23.72%
Interest
6.00
26.00
-20.00
-76.92%
Profit before Depriciation and Tax
260.00
188.00
72.00
38.30%
Depreciation
44.00
46.00
-2.00
-4.35%
Profit Before Taxation & Exceptional Items
216.00
141.00
75.00
53.19%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
216.00
138.00
78.00
56.52%
Provision for Tax
55.00
35.00
20.00
57.14%
Profit After Tax
160.00
103.00
57.00
55.34%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
355.00
282.00
73.00
25.89%
Profit Available for appropriations
516.00
385.00
131.00
34.03%
Appropriations
516.00
385.00
131.00
34.03%
Equity Dividend (%)
45%
45%
0.00
Earnings Per Share
17.56
6.55
11.01
168.09%
Profit And Loss - Net Sales
Net Sales 1,356.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.97% vs 13.29% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 244.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.33% vs 28.31% in Mar 2024
Profit And Loss - Interest
Interest 6.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 54.43% vs -5.14% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 160.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.87% vs 43.89% in Mar 2024






